CAPTRUST Financial Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
AC
VCM
VPM
CAPTRUST Financial Advisors's AVNS Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its Avanos Medical (AVNS) stake by 0.16% in Q1 2026, buying an estimated $243 and bringing the position to 10,984 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.
CAPTRUST Financial Advisors first reported a position in AVNS in Q4 2017 and has held it in 20 quarters since. The position peaked at $261K in Q4 2020. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- CAPTRUST Financial Advisors held 10,984 shares of Avanos Medical worth $154K as of Q1 2026.
- CAPTRUST Financial Advisors bought 18 Avanos Medical shares in Q1 2026, an estimated $243.
- Avanos Medical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2739 holding.
- CAPTRUST Financial Advisors first reported a position in Avanos Medical in Q4 2017 and has held it in 20 quarters since.
- CAPTRUST Financial Advisors's Avanos Medical position peaked at $261K in Q4 2020.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.